Duane Morris Antitrust Class Action Review – 2024

Table Of 2023 Antitrust Class Action Litigation Rulings Second Circuit Borozny, et al. v. Raytheon Technologies Corp., 2023 U.S. Dist. LEXIS 9914 (D. Conn. Jan. 20, 2023).............................................................................................................6 Dennis, et al. v. JPMorgan Chase & Co., Case No. 17 Civ. 6946 (S.D.N.Y. May 25, 2023).............................................................................................................................18 Giordano, et al. v. Saks, 2023 U.S. Dist. LEXIS 17154 (E.D.N.Y. Feb. 1, 2023)..........................6 In Re Google Digital Advertising Antitrust Litigation, 2023 U.S. Dist. LEXIS 97735 (S.D.N.Y. June 5, 2023) ......................................................................................................15 In Re Interest Rate Swaps Antitrust Litigation , Case No. 16-MD-2704 (S.D.N.Y. Dec. 18, 2023).....................................................................................................................13 Iowa Public Employees’ Retirement System, et al. v. Bank Of America Corp., Case No. 17 Civ. 6221 (S.D.N.Y. Sept. 1, 2023) .................................................................18 In Re Namenda Direct Purchaser Antitrust Litigation, Case No. 15 Civ. 7488 (S.D.N.Y. Mar. 23, 2023) .....................................................................................................17 Nostalgic Partners, LLC, et al. v. Office Of The Commissioner Of Baseball, 2023 U.S. App. LEXIS 15258 (2d. Cir. June 20, 2023).................................................................15 In Re Novartis And Par Antitrust Litigation , Case No. 18 Civ. 4361 (S.D.N.Y. Oct. 12, 2023).............................................................................................................................18 In Re Payment Card Interchange Fee and Merchant Discount Antitrust Litigation , No. 20-339 (2d Cir. Mar. 15, 2023)......................................................................................17 Third Circuit In Re Niaspan Antitrust Litigation , 67 F.4th 118 (3d Cir. 2023).........................................5, 13-14 In Re Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation , Case No. 13-MD-2445 (E.D. Penn. Oct. 30, 2023)..............................................18 Value Drug Co., et al. v. Takeda Pharmaceuticals, U.S.A. Inc., 2023 U.S. Dist. LEXIS 33102 (E.D. Pa. Feb. 28, 2023)............................................................................5, 14 Fourth Circuit In Re Zetia (Ezetimibe) Antitrust Litigation, Case No. 18-MD-2836 (E.D. Va. Oct. 18, 2023).............................................................................................................................17

Made with FlippingBook - professional solution for displaying marketing and sales documents online